Pharmacotherapy of type 2 diabetes: An update and future directions
Antea DeMarsilis(Beth Israel Deaconess Medical Center), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Elliot Sternthal(VA Boston Healthcare System), Andreas Filippaios(Beth Israel Deaconess Medical Center), Niyoti Reddy(Boston University), Niki Katsiki(Neurosciences Institute), Chrysoula Boutari(VA Boston Healthcare System)
Cited by 143
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k